{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:32:07Z","timestamp":1780511527858,"version":"3.54.1"},"reference-count":20,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>HepPar-1 and Arginase-1 are urea cycle enzymes used to distinguish hepatocellular carcinoma from other carcinomas. HepPar-1, but not Arginase-1, is known to be immunoreactive with normal human small intestine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To better define and compare the immunohistochemical staining patterns of HepPar-1 and Arginase-1 in adenocarcinomas arising in the small intestine, including the ampullary region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Staining for HepPar-1 and Arginase-1 was performed on 20 nonampullary small intestinal adenocarcinomas and 32 adenocarcinomas from the ampullary region. Ampullary adenocarcinomas were divided into intestinal morphology (15), pancreatobiliary morphology (14), and unclassifiable (3). Nonneoplastic small intestinal mucosa and colorectal adenocarcinomas were used as control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HepPar-1 stained 12 of 20 nonampullary small intestinal adenocarcinomas, with a median of 63% of cells staining in positive cases. It also stained 11 of 15 ampullary carcinomas with intestinal morphology, with a median of 75% of cells staining in positive cases. Two of 14 ampullary carcinomas with pancreatobiliary morphology were positive for HepPar-1. Arginase-1 showed positivity in 2 ampullary region carcinomas and diffuse positivity in 1 duodenal adenocarcinoma. Two of 22 colorectal carcinomas stained for HepPar-1 with none positive for Arginase-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HepPar-1, but not Arginase-1, usually shows positivity in small intestinal adenocarcinomas and ampullary adenocarcinomas with intestinal morphology, but only rarely shows positivity in ampullary adenocarcinomas with pancreatobiliary morphology. HepPar-1 positivity in metastatic adenocarcinoma with intestinal morphology is suggestive of an upper gastrointestinal primary site.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2013-0249-oa","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T09:48:28Z","timestamp":1433238508000},"page":"791-795","source":"Crossref","is-referenced-by-count":17,"title":["HepPar-1 and Arginase-1 Immunohistochemistry in Adenocarcinoma of the Small Intestine and Ampullary Region"],"prefix":"10.5858","volume":"139","author":[{"given":"Stephen","family":"Lagana","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Cell Biology, New York Presbyterian Hospital-Columbia University, New York (Drs Lagana, Hsiao, Sepulveda, Lefkowitch, and Remotti); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Hsaio); the Department of Pathology, Scripps Clinic, San Diego, California (Dr Bao); and the Department of Pathology, Mayo Clinic,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lefkowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Remotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"4","key":"2020081219283438000_i1543-2165-139-6-791-b01","first-page":"1050","article-title":"Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors","volume":"143","author":"Wennerberg","year":"1993","journal-title":"Am J Pathol"},{"issue":"1","key":"2020081219283438000_i1543-2165-139-6-791-b02","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/labinvest.3700699","article-title":"The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1","volume":"88","author":"Butler","year":"2008","journal-title":"Lab Invest"},{"issue":"2","key":"2020081219283438000_i1543-2165-139-6-791-b03","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/002215549804600212","article-title":"Intestinal carbamoyl phosphate synthase I in human and rat: expression during development shows species differences and mosaic expression in duodenum of both species","volume":"46","author":"Van Beers","year":"1998","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"2020081219283438000_i1543-2165-139-6-791-b04","first-page":"262","article-title":"Immunohistochemical features of the gastrointestinal tract tumors","volume":"3","author":"Wong","year":"2012","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"2020081219283438000_i1543-2165-139-6-791-b05","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1309\/AJCPYOBVGS4CGA8Y","article-title":"Hepatocyte paraffin 1 antigen as a biomarker for early diagnosis of Barrett esophagus","volume":"137","author":"Jeung","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2020081219283438000_i1543-2165-139-6-791-b06","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/0031302021000009333","article-title":"Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study","volume":"34","author":"Villari","year":"2002","journal-title":"Pathology"},{"issue":"6","key":"2020081219283438000_i1543-2165-139-6-791-b07","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3346\/jkms.2003.18.6.842","article-title":"Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker","volume":"18","author":"Lee","year":"2003","journal-title":"J Korean Med Sci"},{"issue":"4","key":"2020081219283438000_i1543-2165-139-6-791-b08","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAI.0b013e318229a7cc","article-title":"Hepatocyte antigen (Hep Par 1) is helpful in distinguishing between inflamed and architecturally altered ileal and colonic mucosa","volume":"20","author":"Groisman","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"2020081219283438000_i1543-2165-139-6-791-b09","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1309\/AJCP74XGRFWTFLJU","article-title":"Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma","volume":"132","author":"Cardona","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081219283438000_i1543-2165-139-6-791-b10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1309\/AJCPUD0P5NQBOYPK","article-title":"Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma","volume":"132","author":"Mac","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2020081219283438000_i1543-2165-139-6-791-b11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1309\/KC09YTF2M4DLUYQ6","article-title":"Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples","volume":"122","author":"Lugli","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2020081219283438000_i1543-2165-139-6-791-b12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/PAS.0b013e3181e5dffa","article-title":"Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms","volume":"34","author":"Yan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2020081219283438000_i1543-2165-139-6-791-b13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-8-170","article-title":"Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma","volume":"8","author":"Westgaard","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"2020081219283438000_i1543-2165-139-6-791-b14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer","volume":"105","author":"Kim","year":"2012","journal-title":"J Surg Oncol"},{"issue":"1","key":"2020081219283438000_i1543-2165-139-6-791-b15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00313020701716391","article-title":"Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer?","volume":"40","author":"Gulluoglu","year":"2008","journal-title":"Pathology"},{"issue":"17","key":"2020081219283438000_i1543-2165-139-6-791-b16","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1158\/1078-0432.CCR-05-0278","article-title":"Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis","volume":"11","author":"Fan","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2020081219283438000_i1543-2165-139-6-791-b17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1309\/5C2C-FP3H-GE7Q-2XJ5","article-title":"Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081219283438000_i1543-2165-139-6-791-b18","first-page":"58","article-title":"Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma","volume":"23","author":"Pitman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"11","key":"2020081219283438000_i1543-2165-139-6-791-b19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/PAS.0b013e31826399d8","article-title":"Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081219283438000_i1543-2165-139-6-791-b20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am J Surg Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/791\/1614955\/arpa_2013-0249-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/791\/1614955\/arpa_2013-0249-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:34Z","timestamp":1764790594000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/6\/article-p791.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2013-0249-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}